Zobrazeno 1 - 6
of 6
pro vyhledávání: '"S. A. Sekerko"'
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 1, Pp 47-53 (2010)
Aim: To assess enalapril and telmisartan effects on hemodynamic parameters and left ventricular (LV) diastolic dysfunction (DD) in patients with coronary heart disease (CHD) and arterial hypertension (AH). Material and methods: In total, 51 men with
Externí odkaz:
https://doaj.org/article/adcc4ae91a2942228b84f9f406725553
Autor:
I. P. Tatarchenko, N. B. Pozdnyakova, M. V. Вiryuchenko, O. I. Morozova, A. G. Mordovina, S. A. Sekerko
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 7, Iss 7, Pp 79-84 (2008)
Aim. To investigate the effects of selective, specific If inhibitor ivabradine on electrical myocardial instability predictors in patients with coronary heart disease (CHD).Material and methods. In total, 82 patients with stable CHD, mean age 53,6±4
Externí odkaz:
https://doaj.org/article/21acc242bfe74392ac93f62e8cdf81bf
Autor:
A. G. Mordovina, N. V. Pozdnyakova, I A Petrushin, S A Sekerko, I. P. Tatarchenko, O I Morozova
Publikováno v:
Ischemic Heart Disease
The high rate of disability and mortality among patients with Diabetes Mellitus (DM) is mainly caused by cardiovascular disorders. The pathogenic effect of a number of specific factors (hyperglycemia, hyperinsulinemia, insulin resistance) accelerates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7892118bac389a15c16190cbeca7cfa3
https://doi.org/10.5772/53445
https://doi.org/10.5772/53445
Publikováno v:
Kardiologiia. 51(4)
Effect of enalapril and telmisartan on hemodynamic indices, structural-functional parameters of the left ventricle, and vasomotor function of arterial endothelium was studied in 49 patients (mean age 48.3+/-3.2 years) with 1-2 degree arterial hyperte
Publikováno v:
Klinicheskaia meditsina. 87(10)
The study was designed to evaluate effect of enalapril and telmisartan on hemodynamic characteristics and diastolic function (DF) of left ventricle (LV) in patients with type 2 diabetes and arterial hypertension (AH). It included 64 patients aged 54.
Autor:
I P, Tatarchenko, N V, Pozdniakova, M V, Biriuchenko, V Iu, Kapelovich, S A, Sekerko, R A, Kupaeva
Publikováno v:
Terapevticheskii arkhiv. 80(9)
To assess ivabradin and nebivolol efficacy in combined treatment of ischemic heart disease patients with chronic heart failure (CHF) of functional class (FC) II-III by NYHA, impact of these drugs on quality of life, circadian indices of myocardial is